Homburger advised Deutsche Bank on a syndicated German law bridge financing of the battery producer, Varta. The deal will allow the company to finalize its current restructuring in the context of the German StaRUG (German Act on the Stabilisation and Restructuring Framework for Companies). This will support the Varta’s core industry, safeguarding jobs and value […]
Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics on all Swiss legal matters in connection with the direct offering and concurrent private placement transaction with certain investors to issue 806,452 of common shares and 806,452
On 10 October 2024, the City of Bellinzona successfully completed its inaugural issuance of CHF 125 million 1.05 percent bonds due 2035. The bonds have been listed on the SIX Swiss Exchange. Bank Vontobel was the sole lead manager for
On September 23, 2024, UBS Switzerland, advised by Homburger and Walder Wyss, successfully completed its issuance of EUR 1 billion fixed rate covered bonds due September 23, 2027 under its covered bond programme. The Covered Bonds are governed by Swiss
Niederer Kraft Frey (“NKF”) advised Brusa Elektronik, a Swiss based technology company in the field of development, manufacturing and distribution of power electronics used for battery electrical vehicles which has completed a carve-out transaction of
Niederer Kraft Frey (NKF) has acted as legal advisor to Axpo Holding AG in securing a JPY 42 billion (approximately CHF 250 million) Samurai loan. The financing is aimed at supporting Axpo’s current business operations and
Homburger has advised the Joint-Lead Managers (UBS Investment Bank, Deutsche Bank AG, J.P. Morgan, and Natixis) on Swiss Life Finance II AG’s successful issuance of EUR 500 million callable subordinated capital securities, with a
Baker McKenzie Switzerland served as local Swiss counsel for Cimpress plc (Nasdaq: CMPR) on its private offering of USD 525 million in aggregate principal amount of 7.375% senior notes due 2032 and the amendment of its existing credit
MLL Legal assisted GCLH and Meanquest on the purchase of a majority stake in the company MIB Suisse . GCLH and Meanquest will bring their know-how to MIB’s customers through its various business lines, including
Advestra acted as Swiss legal counsel to Novartis, which successfully placed notes in the aggregate principal amount of USD 3.7 billion in four tranches of USD 1 billion 3.800%
